Does SUNITINIB Cause Hepatic neoplasm? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatic neoplasm have been filed in association with SUNITINIB. This represents 0.3% of all adverse event reports for SUNITINIB.
5
Reports of Hepatic neoplasm with SUNITINIB
0.3%
of all SUNITINIB reports
3
Deaths
1
Hospitalizations
How Dangerous Is Hepatic neoplasm From SUNITINIB?
Of the 5 reports, 3 (60.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Hepatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUNITINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does SUNITINIB Cause?
Disease progression (280)
Drug ineffective (243)
Malignant neoplasm progression (242)
Fatigue (132)
Diarrhoea (129)
Osteonecrosis of jaw (115)
Hypertension (99)
Off label use (99)
Thrombocytopenia (96)
Death (85)
What Other Drugs Cause Hepatic neoplasm?
OCTREOTIDE (300)
ADALIMUMAB (98)
LANREOTIDE (85)
EVEROLIMUS (84)
AMLODIPINE (74)
ROSUVASTATIN (55)
IMATINIB (51)
BEVACIZUMAB (49)
RIBAVIRIN (49)
METFORMIN (47)
Which SUNITINIB Alternatives Have Lower Hepatic neoplasm Risk?
SUNITINIB vs SUNITINIB MALATE
SUNITINIB vs SUTENT
SUNITINIB vs SUTIMLIMAB-JOME
SUNITINIB vs SUVOREXANT
SUNITINIB vs SUZETRIGINE